




Healthcare News Roundup: Biopharmaceutical
HSMN NewsFeed - 4 Apr 2025
Neurocrine Biosciences Appoints Dr. Sanjay Keswani as Chief Medical Officer
Neurocrine Biosciences Appoints Dr. Sanjay Keswani as Chief Medical Officer
HSMN NewsFeed - 31 Mar 2025
Orna Therapeutics Appoints Joseph Bolen, Ph.D., as Chief Executive Officer
Orna Therapeutics Appoints Joseph Bolen, Ph.D., as Chief Executive Officer
HSMN NewsFeed - 31 Mar 2025
Lomond Therapeutics Completes Second and Third Closings and adds Two New Investors
Lomond Therapeutics Completes Second and Third Closings and adds Two New Investors
HSMN NewsFeed - 25 Mar 2025
Hubble Therapeutics Closes Series A Financing to Develop Gene Therapy Cure for LCA16
Hubble Therapeutics Closes Series A Financing to Develop Gene Therapy Cure for LCA16
HSMN NewsFeed - 20 Mar 2025
Bristol Myers Squibb Appoints Osama Braiwish as General Manager for Saudi Arabia & Gulf Countries
Bristol Myers Squibb Appoints Osama Braiwish as General Manager for Saudi Arabia & Gulf Countries
HSMN NewsFeed - 17 Mar 2025
Latigo Biotherapeutics Closes $150 Million in Series B Financing to Advance Non-Opioid Pain Therapeutics
Latigo Biotherapeutics Closes $150 Million in Series B Financing to Advance Non-Opioid Pain Therapeutics
HSMN NewsFeed - 17 Mar 2025
Surf Bio Appoints Industry Veteran Doug Hecker as Head of Technical Operations
Surf Bio Appoints Industry Veteran Doug Hecker as Head of Technical Operations
HSMN NewsFeed - 13 Mar 2025
Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader
Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader
HSMN NewsFeed - 5 Mar 2025
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio